{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/BCLI/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-17T01:28:29.003Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":12335,"canonical_name":"BRAINSTORM CELL THERAPEUTICS INC.","cik":"0001137883","uei":null,"lei":null,"duns":null,"ticker":"BCLI"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":20},"count":20,"timeline":[{"ts":"2026-08-14","kind":"sec.filing","form_type":"10-Q","title":"10-Q — BRAINSTORM CELL THERAPEUTICS INC. — 2026-08-14","url_slug":"/sec/cik-0001137883/10-q/0001104659-26-097275","accession_number":"0001104659-26-097275","importance":45},{"ts":"2026-08-14","kind":"sec.filing","form_type":"8-K","title":"8-K — BRAINSTORM CELL THERAPEUTICS INC. — 2026-08-14","url_slug":"/sec/cik-0001137883/8-k/0001104659-26-097180","accession_number":"0001104659-26-097180","importance":35},{"ts":"2026-07-30","kind":"sec.filing","form_type":"8-K","title":"8-K — BRAINSTORM CELL THERAPEUTICS INC. — 2026-07-30","url_slug":"/sec/cik-0001137883/8-k/0001104659-26-088728","accession_number":"0001104659-26-088728","importance":35},{"ts":"2026-07-28","kind":"sec.filing","form_type":"4","title":"4 — BRAINSTORM CELL THERAPEUTICS INC. — 2026-07-28","url_slug":"/sec/cik-0001137883/4/0001104659-26-087584","accession_number":"0001104659-26-087584","importance":30},{"ts":"2026-07-28","kind":"sec.filing","form_type":"4","title":"4 — BRAINSTORM CELL THERAPEUTICS INC. — 2026-07-28","url_slug":"/sec/cik-0001137883/4/0001104659-26-087588","accession_number":"0001104659-26-087588","importance":30},{"ts":"2026-07-24","kind":"sec.insider.a","reporter":"FRENKEL JACOB A","title":"","shares":100000,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-03","kind":"sec.filing","form_type":"3","title":"3 — BRAINSTORM CELL THERAPEUTICS INC. — 2026-06-03","url_slug":"/sec/cik-0001137883/3/0001104659-26-070209","accession_number":"0001104659-26-070209","importance":30},{"ts":"2026-06-02","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — BRAINSTORM CELL THERAPEUTICS INC. — 2026-06-02","url_slug":"/sec/cik-0001137883/effect/9999999995-26-001853","accession_number":"9999999995-26-001853","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"CORRESP","title":"CORRESP — BRAINSTORM CELL THERAPEUTICS INC. — 2026-06-01","url_slug":"/sec/cik-0001137883/corresp/0001104659-26-068906","accession_number":"0001104659-26-068906","importance":30},{"ts":"2026-05-27","kind":"sec.filing","form_type":"UPLOAD","title":"UPLOAD — BRAINSTORM CELL THERAPEUTICS INC. — 2026-05-27","url_slug":"/sec/cik-0001137883/upload/0000000000-26-005403","accession_number":"0000000000-26-005403","importance":30},{"ts":"2026-05-21","kind":"sec.filing","form_type":"S-1","title":"S-1 — BRAINSTORM CELL THERAPEUTICS INC. — 2026-05-21","url_slug":"/sec/cik-0001137883/s-1/0001104659-26-064628","accession_number":"0001104659-26-064628","importance":65},{"ts":"2026-05-21","kind":"sec.filing","form_type":"S-8","title":"S-8 — BRAINSTORM CELL THERAPEUTICS INC. — 2026-05-21","url_slug":"/sec/cik-0001137883/s-8/0001104659-26-064632","accession_number":"0001104659-26-064632","importance":30},{"ts":"2026-05-20","kind":"sec.filing","form_type":"4","title":"4 — BRAINSTORM CELL THERAPEUTICS INC. — 2026-05-20","url_slug":"/sec/cik-0001137883/4/0001104659-26-064650","accession_number":"0001104659-26-064650","importance":30},{"ts":"2026-05-20","kind":"sec.filing","form_type":"4","title":"4 — BRAINSTORM CELL THERAPEUTICS INC. — 2026-05-20","url_slug":"/sec/cik-0001137883/4/0001104659-26-064652","accession_number":"0001104659-26-064652","importance":30},{"ts":"2026-05-20","kind":"sec.filing","form_type":"4","title":"4 — BRAINSTORM CELL THERAPEUTICS INC. — 2026-05-20","url_slug":"/sec/cik-0001137883/4/0001104659-26-064653","accession_number":"0001104659-26-064653","importance":30},{"ts":"2026-05-20","kind":"sec.filing","form_type":"4","title":"4 — BRAINSTORM CELL THERAPEUTICS INC. — 2026-05-20","url_slug":"/sec/cik-0001137883/4/0001104659-26-064656","accession_number":"0001104659-26-064656","importance":30},{"ts":"2026-05-20","kind":"sec.filing","form_type":"4","title":"4 — BRAINSTORM CELL THERAPEUTICS INC. — 2026-05-20","url_slug":"/sec/cik-0001137883/4/0001104659-26-064657","accession_number":"0001104659-26-064657","importance":30},{"ts":"2026-05-20","kind":"sec.filing","form_type":"4","title":"4 — BRAINSTORM CELL THERAPEUTICS INC. — 2026-05-20","url_slug":"/sec/cik-0001137883/4/0001104659-26-064658","accession_number":"0001104659-26-064658","importance":30},{"ts":"2026-05-15","kind":"sec.filing","form_type":"10-Q","title":"10-Q — BRAINSTORM CELL THERAPEUTICS INC. — 2026-05-15","url_slug":"/sec/cik-0001137883/10-q/0001104659-26-062648","accession_number":"0001104659-26-062648","importance":45},{"ts":"2026-05-15","kind":"sec.filing","form_type":"8-K","title":"8-K — BRAINSTORM CELL THERAPEUTICS INC. — 2026-05-15","url_slug":"/sec/cik-0001137883/8-k/0001104659-26-062766","accession_number":"0001104659-26-062766","importance":35}]}